Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,865.00    170.00 (2.54%)
Bid:
6,865.00
Ask:
6,875.00
Spread: 10.00 (0.146%)
Market Cap: £5.07b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

25 May 2010 13:30

RNS Number : 5064M
Spirax-Sarco Engineering PLC
25 May 2010
 



 

 

Spirax-Sarco Engineering plc

 

Charlton House

Cheltenham

Glos. GL53 8ER

 

 

News Release

 

 

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

 

25th May 2010

 

 

Spirax Sarco acquires remaining 51% equity in Mexican Associate Company for £10.7 million 

 

Spirax-Sarco Engineering plc announces that it has acquired from its local partners the remaining 51% voting equity in its Mexican operating company, Spirax-Sarco Mexicana S.A. ("Spirax Mexico"), which was previously 49% owned by the Group and accounted as an Associate.

 

Spirax Mexico has been Spirax Sarco's exclusive licensee and distributor for Mexico since 1980, successfully growing the business and establishing Spirax Sarco as the market leader. We are pleased to gain full control in this strategically important market that has the 13th largest economy in the world and the 11th largest population. The Mexican industrial steam‑using base, that is Spirax Mexico's target market, is expected to provide good future growth prospects as we invest and increase focus in this developing market.

 

The purchase consideration for the 51% of Spirax Mexico not previously controlled by the Group is MX$201.9 million (£10.7 million), which will be settled in instalments over an expected five year period from existing Group resources. It is anticipated that the business will have net cash balances in excess of £1m at Closing. Trading has started well in 2010 and we expect the transaction to make a small positive contribution to Group earnings in the second half of 2010.

 

Accounting changes

Under the provisions of amended IFRS3, which will apply to the Group for 2010, the results of Spirax Mexico will, with effect from 25th May 2010 onwards, be fully consolidated with sales and operating profit included in the Americas segment in the Group results. Up to this date, Spirax Mexico will continue to be accounted for as an Associate with 49% of the after-tax profit for this period included within Associates in the Group Income Statement. In addition, as required by IFRS3, the 2010 Group accounts will reflect the uplift in the current book value of the Group's existing 49% investment, which will be shown as an exceptional profit of approximately £8 million in the Group Income Statement.

 

About Spirax Sarco

Spirax-Sarco Engineering plc provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com.

 

 

Contact details:

 

Mark Vernon - Chief Executive

David Meredith - Director Finance

 

 

Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Gloucestershire

GL53 8ER

 

Tel: 01242 535234

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAASSAANEEFF
Date   Source Headline
21st Nov 20173:08 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSTrading Statement
14th Nov 201710:39 amRNSDirector/PDMR Shareholding
16th Oct 20175:35 pmRNSDirector/PDMR Shareholding
29th Sep 20173:36 pmRNSHolding(s) in Company
9th Aug 20177:00 amRNSHalf-year Report
4th Jul 20177:00 amRNSCompletion of Acquisition
23rd Jun 20179:11 amRNSTotal Voting Rights
20th Jun 20173:59 pmRNSHolding(s) in Company
12th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20179:08 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSAcquisition of Chromalox for US$415 million
9th May 20174:30 pmRNSResult of AGM
9th May 20177:00 amRNSTrading Statement
4th May 20174:30 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSCompletion of Acquisition
26th Apr 20178:42 amRNSHolding(s) in Company
25th Apr 20179:10 amRNSHolding(s) in Company
19th Apr 20173:55 pmRNSHolding(s) in Company
18th Apr 20173:58 pmRNSHolding(s) in Company
3rd Apr 20177:30 amRNSAcquisition
24th Mar 20174:44 pmRNSTotal Voting Rights
23rd Mar 20171:45 pmRNSDirector/PDMR Shareholding
17th Mar 20174:04 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSFinal Results
30th Nov 20167:00 amRNSAcquisition
22nd Nov 20167:00 amRNSTrading Statement
17th Nov 20164:23 pmRNSDirector/PDMR Shareholding
14th Nov 20168:30 amRNSDr Krishnamurthy Rajagopal
10th Nov 201611:40 amRNSListing Application
8th Nov 201611:57 amRNSChange of Director Details
4th Nov 20164:27 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSBoard Succession Changes
17th Oct 20162:49 pmRNSAdditional Listing
14th Oct 20165:03 pmRNSDirector/PDMR Shareholding
14th Oct 20163:20 pmRNSTotal Voting Rights
14th Oct 20163:17 pmRNSBlock listing Interim Review
6th Oct 201611:48 amRNSNotification of Release Date - Trading Statement
8th Sep 201612:44 pmRNSTotal Voting Rights
18th Aug 20168:30 amRNSBoard Appointment
12th Aug 20163:51 pmRNSDirector/PDMR Shareholding
9th Aug 20167:05 amRNSSpirax Sarco acquires assets of Hiter for £3.9 m
9th Aug 20167:00 amRNS2016 Half Year Results
5th Aug 20162:56 pmRNSTotal Voting Rights
1st Jul 201611:43 amRNSTotal Voting Rights
29th Jun 20169:29 amRNSNotice of Results
21st Jun 20165:40 pmRNSDirector/PDMR Shareholding
10th Jun 20162:59 pmRNSHolding(s) in Company
2nd Jun 20164:20 pmRNSAdditional Listing
2nd Jun 20163:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.